Kokolakis G, Warren RB, Strober B, Blauvelt A, et al. Bimekizumab efficacy and safety in patients with moderate-to-severe plaque psoriasis who switched from adalimumab, ustekinumab or secukinumab: results from phase III/IIIb trials. Br J Dermatol 2022 Nov 29:ljac089. doi: 10.1093.
PMID: 36751950